XPERNATO-TOX/NN
:/:
an/DT
Integrated/JJ
Toxicogenomics/NNS
./.
====================
Knowledgebase/NN
====================
Toxicogenomics/NNS
combines/NNS
transcriptome/VBP
,/,
proteome/VBP
and/CC
metabolome/JJ
profiling/VBG
with/IN
conventional/JJ
toxicology/NN
to/TO
investigate/VB
the/DT
interaction/NN
between/IN
biological/JJ
molecules/NNS
and/CC
toxicant/JJ
or/CC
environmental/JJ
stress/NN
in/IN
disease/NN
caution/NN
./.
====================
Toxicogenomics/NNS
faces/NNS
the/DT
problems/NNS
of/IN
comparison/NN
and/CC
integration/NN
across/IN
different/JJ
sources/NNS
of/IN
data/NNS
./.
====================
Cause/NN
of/IN
unusual/JJ
characteristics/NNS
of/IN
toxicogenomic/JJ
data/NNS
,/,
researcher/RB
should/MD
be/VB
assisted/VBN
by/IN
data/NNS
analysis/NN
and/CC
annotation/NN
for/IN
getting/VBG
meaningful/JJ
information/NN
./.
====================
There/EX
are/VBP
already/RB
existing/VBG
repositories/VBZ
which/WDT
claim/NN
to/TO
stand/VB
for/IN
toxicogenomics/NNS
database/NN
./.
====================
However/RB
,/,
those/DT
just/RB
contain/VBP
limited/JJ
abilities/NNS
for/IN
toxicogenomic/JJ
research/NN
./.
====================
For/IN
supporting/VBG
toxicologist/NN
who/WP
comes/VBZ
up/IN
against/IN
toxicogenomic/JJ
data/NNS
flood/NN
,/,
now/RB
we/PRP
propose/VBP
novel/JJ
toxicogenomics/NNS
knowledgebase/NN
system/NN
,/,
XPERANTO-TOX/NN
./.
====================
XPERANTO-TOX/NN
is/VBZ
an/DT
integrated/JJ
system/NN
for/IN
toxicogenomic/JJ
data/NNS
management/VBP
and/CC
analysis/NN
./.
====================
It/PRP
is/VBZ
composed/VBN
of/IN
three/CD
distinct/JJ
but/CC
closely/RB
connected/VBD
parts/NNS
./.
====================
Firstly/RB
,/,
Data/NNS
Storage/NN
System/NN
is/VBZ
for/IN
reposit/NN
many/JJ
kinds/NNS
of/IN
'-omics/NNS
1/CD
data/NNS
and/CC
conventional/JJ
toxicology/NN
data/NNS
./.
====================
Secondly/RB
,/,
Data/NNS
Analysis/NN
System/NN
consists/VBZ
of/IN
analytical/JJ
modules/NNS
for/IN
integrated/JJ
toxicogenomics/NNS
data/NNS
./.
====================
At/IN
last/JJ
,/,
Data/NNS
Annotation/NN
System/NN
is/VBZ
for/IN
giving/VBG
extensive/JJ
insight/NN
of/IN
data/NNS
to/TO
researcher/VB
./.
====================
Toxicology/NN
is/VBZ
study/NN
to/TO
understand/VB
the/DT
relationship/NN
between/IN
====================
toxicants/NNS
,/,
and/CC
human/JJ
disease/NN
susceptibility/NN
./.
====================
A/DT
critical/JJ
part/NN
of/IN
this/DT
study/NN
is/VBZ
the/DT
characterization/NN
of/IN
the/DT
adverse/JJ
effects/NNS
at/IN
the/DT
level/NN
of/IN
the/DT
organism/NN
,/,
the/DT
tissue/NN
,/,
the/DT
cell/NN
,/,
and/CC
the/DT
molecular/JJ
makeup/NN
of/IN
the/DT
cell/NN
./.
====================
Thus/RB
,/,
studies/NNS
in/IN
toxicology/NN
measure/VB
effects/NNS
on/IN
body/NN
weight/NN
and/CC
food/NN
consumption/NN
of/IN
an/DT
organism/NN
,/,
on/IN
individual/JJ
organ/NN
weights/NNS
,/,
on/IN
microscopic/JJ
histopathology/NN
of/IN
tissues/NNS
,/,
and/CC
on/IN
cell/NN
viability/NN
,/,
necrosis/NN
,/,
and/CC
apoptosis/NN
(/(
Waters/NNS
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Recently/RB
,/,
cause/VBP
of/IN
the/DT
appearance/NN
of/IN
new/JJ
'-omics/NNS
'/``
technology/NN
,/,
toxicologist/NN
could/MD
get/VB
the/DT
extensive/JJ
information/NN
of/IN
molecular/JJ
level/NN
(/(
Hamadeh/NN
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
That/DT
is/VBZ
,/,
'new/JJ
-omics/NNS
technology/NN
1/CD
,/,
such/JJ
as/IN
transcriptomics/NNS
,/,
proteomics/NNS
and/CC
metabolomics/NNS
have/VBP
been/VBN
developed/VBN
,/,
therefore/RB
toxicologist/NN
can/MD
measure/VB
thousands/NNS
of/IN
movement/JJ
of/IN
transcriptome/JJ
or/CC
proteome/JJ
(/(
Aardema/NNP
et/FW
al./FW
,/,
2002/CD
)/)
./.
====================
Obviously/RB
,/,
variations/NNS
at/IN
cellular/JJ
and/CC
organism/NN
level/NN
are/VBP
caused/VBN
by/IN
critical/JJ
changes/NNS
of/IN
mRNAs/NNS
or/CC
proteins/NNS
./.
====================
So/RB
the/DT
application/NN
of/IN
new/JJ
technologies/NNS
to/TO
conventional/JJ
toxicology/NN
gives/VBZ
insight/NN
into/IN
‘/NN
cause/VBP
and/CC
effect/NN
chain/NN
’/CD
of/IN
organism/NN
./.
====================
As/IN
mentioned/VBN
of/IN
changes/NNS
of/IN
toxicology/NN
,/,
the/DT
new/JJ
term/NN
Toxicogenomics/NNS
has/VBZ
been/VBN
evolved/VBN
./.
====================
Toxicogenomics/NNS
could/MD
be/VB
demonstrated/VBN
of/IN
integration/NN
of/IN
conventional/JJ
====================
toxicology/NN
and/CC
'-omics/NNS
'/``
technologies/NNS
./.
====================
To/TO
study/VB
of/IN
combining/VBG
genomic/JJ
changes/NNS
and/CC
biological/JJ
endpoints/NNS
,/,
collection/NN
of/IN
heterogeneous/JJ
data/NNS
has/VBZ
become/VBN
challenge/NN
of/IN
toxicogenomics/NNS
(/(
Mattes/NNS
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Fig/NN
./.
====================
1/CD
shows/VBZ
the/DT
overview/NN
of/IN
current/JJ
toxicogenomics/NNS
./.
====================
From/IN
model/NN
animal/NN
,/,
data/NNS
flow/NN
of/IN
clockwise/JJ
rotation/NN
indicates/VBZ
data/NNS
gathering/VBG
with/IN
‘/NN
-new/JJ
omics/NNS
'/``
technology/NN
./.
====================
There/EX
are/VBP
proteomics/NNS
,/,
transcriptomics/VBZ
,/,
metabolomics/NNS
,/,
arrayCGH/NN
,/,
and/CC
tissue/NN
microarray/NN
which/WDT
generate/VBP
high-/JJ
throughput/NN
expression/NN
data/NNS
(/(
Waters/NNS
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
Opposite/JJ
flow/NN
indicates/VBZ
data/NNS
gathering/VBG
in/IN
conventional/JJ
toxicology/NN
./.
====================
There/EX
could/MD
be/VB
histopathology/NN
,/,
clinical/JJ
chemistry/NN
,/,
physiology/NN
and/CC
so/RB
on/IN
(/(
Laura/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Those/DT
two/CD
processes/NNS
yield/VBP
heterogeneous/JJ
data/NNS
that/WDT
can/MD
not/RB
be/VB
combined/VBN
easily/RB
,/,
so/RB
well-designed/JJ
knowledgebase/NN
which/WDT
is/VBZ
able/JJ
to/TO
store/VB
such/JJ
types/NNS
of/IN
data/NNS
has/VBZ
been/VBN
needed/VBN
./.
====================
Data/NNS
Analysis/NN
represented/VBN
on/IN
bottom/CC
left/NN
of/IN
the/DT
Fig/NN
./.
====================
1/CD
reduce/VBP
enormous/JJ
but/CC
unfocused/JJ
genomic/JJ
data/NNS
to/TO
significant/JJ
one/CD
by/IN
several/JJ
statistical/JJ
and/CC
computational/JJ
modules/NNS
./.
====================
Then/RB
analyzed/VBD
data/NNS
become/VBP
small/JJ
enough/IN
to/TO
handle/NN
./.
====================
But/CC
in/IN
general/JJ
,/,
it/PRP
is/VBZ
still/RB
too/RB
huge/JJ
to/TO
be/VB
interpreted/VBN
./.
====================
Data/NNS
Annotation/NN
is/VBZ
also/RB
important/JJ
for/IN
====================
that/DT
reason/NN
./.
====================
Analysts/NNS
easily/RB
get/NN
meaningful/JJ
information/NN
from/IN
toxicogenomic/JJ
data/NNS
composed/VBN
of/IN
just/RB
an/DT
array/NN
of/IN
numbers/NNS
and/CC
tiny/JJ
indices/VBZ
./.
====================
Currently/RB
,/,
there/EX
are/VBP
several/JJ
repositories/NNS
which/WDT
claim/NN
to/TO
stand/VB
for/IN
Toxicogenomics/NNS
database/NN
(/(
or/CC
knowledgebase/JJ
)/)
’/CD
(/(
Mattes/NNS
etal./FW
,/,
2004/CD
)/)
./.
====================
However/RB
,/,
they/PRP
are/VBP
still/RB
not/RB
enough/IN
to/TO
stand/VB
for/IN
toxicogenomics/NNS
knowledgebase/NN
(/(
Table/JJ
1/CD
)/)
./.
====================
Most/JJS
listed/VBN
databases/NNS
are/VBP
not/RB
able/JJ
to/TO
include/VB
conventional/JJ
toxicology/NN
./.
====================
Even/RB
though/IN
there/EX
are/VBP
databases/NNS
have/VBP
analysis/NN
system/NN
,/,
they/PRP
perform/VBP
only/RB
lower/JJR
level/NN
analysis/NN
just/RB
as/IN
’/CD
simple/JJ
t-test/JJS
’/CD
./.
====================
For/IN
getting/VBG
enough/IN
insight/NN
from/IN
high-/JJ
throughput/NN
data/NNS
,/,
it/PRP
should/MD
be/VB
able/JJ
to/TO
perform/VB
higher/JJR
level/NN
analysis/NN
./.
====================
In/IN
addition/NN
,/,
extra/JJ
data/NNS
for/IN
annotate/JJ
primary/JJ
one/CD
still/RB
insufficient/JJ
in/IN
most/JJS
cases/NNS
./.
====================
Therefore/RB
the/DT
actual/JJ
circumstances/NNS
,/,
toxicologist/NN
can/MD
not/RB
gather/RBR
enough/IN
resources/VBZ
from/IN
existing/VBG
repositories/VBZ
./.
====================
In/IN
this/DT
paper/NN
,/,
we/PRP
propose/VBP
a/DT
novel/JJ
system/NN
‘/CD
XPERANTO/NN
-/:
TOX/NN
’/CD
to/TO
complement/VB
limitation/NN
of/IN
existing/VBG
toxicogenomics/NNS
repositories/VBZ
./.
====================
MIAME-TOX/NN
(/(
http/NN
:/:
//www.mged.org/JJ
)/)
and/CC
TMA-OM/NN
(/(
Lee/NNP
et/FW
al./FW
,/,
2005/CD
)/)
were/VBD
used/VBN
as/IN
data/NNS
standard/RB
for/IN
storage/NN
system/NN
./.
====================
MIAME-TOX/NN
is/VBZ
an/DT
extended/JJ
version/NN
of/IN
MIAME/NN
(/(
Minimum/NN
Information/NN
About/NN
an/DT
Microarray/NN
Experiment/JJ
)/)
./.
====================
That/DT
is/VBZ
,/,
MIAME-TOX/NN
is/VBZ
a/DT
guideline/NN
defining/VBG
the/DT
minimum/JJ
information/NN
required/VBD
to/TO
interpret/VB
unambiguously/RB
and/CC
potentially/RB
reproduce/VBP
and/CC
verify/RB
array-based/VBN
toxicogenomic/JJ
experiments/NNS
./.
====================
TMA-OM/NN
(/(
Tissue/NN
Microarray/NN
-/:
Object/JJ
Model/NN
)/)
is/VBZ
a/DT
data/NNS
model/NN
for/IN
capturing/VBG
tissue/NN
microarray/NN
experimental/JJ
data/NNS
and/CC
representing/VBG
clinical/JJ
and/CC
histopathology/NN
information/NN
of/IN
tissues/NNS
./.
====================
Otherwise/JJ
there/EX
are/VBP
no/DT
gold/NN
standard/JJ
for/IN
conventional/JJ
toxicology/NN
data/NNS
,/,
such/JJ
as/IN
histopathology/NN
image/NN
and/CC
description/NN
./.
====================
So/RB
we/PRP
referenced/VBD
sample/NN
description/NN
part/NN
of/IN
two/CD
mentioned/JJ
data/NNS
model/NN
./.
====================
There/EX
are/VBP
several/JJ
steps/NNS
for/IN
getting/VBG
meaningful/JJ
information/NN
from/IN
high-dimensional/JJ
data/NNS
./.
====================
Data/NNS
analysis/NN
system/NN
in/IN
XPERANTO-TOX/NN
has/VBZ
been/VBN
developed/VBN
based/VBN
on/IN
these/DT
steps/NNS
./.
====================
Statistical/JJ
language/NN
R/NN
(/(
current/JJ
version/NN
R/NN
2.2/CD
)/)
was/VBD
used/VBN
for/IN
materializing/VBG
most/JJS
modules/NNS
in/IN
analysis/NN
system/NN
./.
====================
VSN/RB
(/(
variance/NN
stabilizing/VBG
transformation/NN
)/)
(/(
Huber/NNP
etal./FW
,/,
2002/CD
)/)
,/,
KNN/NN
(/(
K/NN
Nearest/JJS
Neighbor/CC
)/)
,/,
cyclic/JJ
lowess/RBR
,/,
global/JJ
lowess/RBR
and/CC
several/JJ
baseline/NN
normalization/NN
algorithms/NNS
(/(
Bolstard/JJ
et/FW
al./FW
,/,
2003/CD
)/)
were/VBD
used/VBN
for/IN
data/NNS
preprocessing/VBG
step/NN
./.
====================
Significant/JJ
Analysis/NN
for/IN
Microarrays/NNS
(/(
Virginia/NNP
et/FW
al./FW
,/,
2001/CD
)/)
,/,
cyberT/JJ
(/(
Baldi/NNP
et/FW
al./FW
,/,
2001/CD
)/)
,/,
DEDS/NNP
(/(
Differential/JJ
Expression/NN
via/IN
Distance/NN
Summary/JJ
of/IN
Multiple/JJ
Statistics/NNS
Description/NN
)/)
(/(
Yee/NNP
et/FW
al./FW
,/,
2005/CD
)/)
,/,
ANOVA/NNP
(/(
Analysis/NN
Of/IN
Variance/NN
)/)
,/,
bayesANOVA/RB
(/(
Baldi/NNP
et/FW
al./FW
,/,
2001/CD
)/)
,/,
GSEA/NN
(/(
Gene/NN
Set/NN
Enrichment/JJ
Study/NN
)/)
(/(
Aravind/NNP
et/FW
al./FW
,/,
2005/CD
)/)
and/CC
other/JJ
algorithms/NNS
were/VBD
used/VBN
for/IN
significant/JJ
data/NNS
analysis/NN
step/RB
./.
====================
Hierarchical/JJ
,/,
K-means/NNS
,/,
SOM/NN
(/(
Self/NN
Organizing/JJ
Map/NN
)/)
,/,
PCA/NN
(/(
Principle/NN
Component/JJ
Analysis/NN
)/)
,/,
ICA/NN
(/(
Independent/JJ
Component/JJ
Analysis/NN
)/)
(/(
Samir/NN
etal./FW
,/,
====================
2004/CD
)/)
algorithms/VBZ
were/VBD
used/VBN
for/IN
clustering/NN
data/NNS
elements/NNS
./.
====================
At/IN
last/JJ
,/,
SVM/NN
(/(
Support/NN
Vector/NN
Machine/NN
)/)
(/(
Brown/JJ
et/FW
al./FW
,/,
2000/CD
)/)
and/CC
PAM/NN
(/(
Prediction/NN
Analysis/NN
of/IN
Microarray/NN
)/)
(/(
Robert/NNP
et/FW
al./FW
,/,
2002/CD
)/)
were/VBD
used/VBN
for/IN
classification/NN
./.
====================
We/PRP
localized/VBD
GenBank/NN
(/(
http/NN
:/:
//www.ncbi.nlm.nih.gov/Genbank//JJ
index.html/NN
)/)
,/,
UniGene/JJ
(/(
http/NN
:/:
//www.ncbi.nlm.nih.gov/entrez//JJ
query.fcgi/RB
?/.
db=unigene/NN
)/)
,/,
Entrez/NN
Gene/NN
(/(
http/NN
:/:
//www.ncbi/LS
./.
====================
nlm.nih.gov/entrez/query.fcgi/RB
?/.
db=gene/NN
)/)
,/,
SWISSPROT/NN
(/(
http/NN
:/:
//www.expasy.org/sprot//JJ
)/)
databases/NNS
for/IN
composing/VBG
'Gene/NN
'/``
part/NN
in/IN
annotation/NN
system/NN
./.
====================
CTD/NN
(/(
Comparative/JJ
Toxicogenomic/JJ
Database/NN
)/)
(/(
Carolyn/NN
etal./FW
,/,
2003/CD
)/)
,/,
ArrayTrack/NN
(/(
Wieda/NN
et/FW
al./FW
,/,
2003/CD
)/)
were/VBD
localized/VBN
for/IN
‘/NN
Toxicant/JJ
’/CD
part/NN
./.
====================
‘/CD
Disease/NN
’/CD
part/NN
was/VBD
composed/VBN
of/IN
OMIM/NN
(/(
http/NN
:/:
//www.ncbi/NN
./.
====================
nlm.nih.gov/entrez/query.fcgi/RB
?/.
db=OMIM/NN
)/)
,/,
MeSH/NN
term/NN
data/NNS
./.
====================
For/IN
connecting/VBG
each/DT
part/NN
,/,
we/PRP
referenced/VBD
CTD/NN
for/IN
gene-toxicant/JJ
,/,
PathMeSH/NN
for/IN
gene-disease/NN
and/CC
CHE/NN
(/(
http/NN
:/:
//database.healthandenvironment.org//JJ
)/)
for/IN
toxicant­/NN
disease/NN
connection/NN
./.
====================
XPERANTO-TOX/NN
is/VBZ
developed/VBN
as/IN
a/DT
large/JJ
system/NN
composed/VBN
of/IN
closely/RB
connected/VBD
three/CD
sub/JJ
systems/NNS
(/(
Fig/NN
./.
====================
Researcher/RB
could/MD
reposit/VB
heterogeneous/JJ
data/NNS
generated/VBD
from/IN
various/JJ
types/NNS
of/IN
experiments/NNS
./.
====================
The/DT
system/NN
is/VBZ
designed/VBN
with/IN
MIAME-TOX/NN
for/IN
storing/VBG
data/NNS
which/WDT
is/VBZ
produced/VBN
by/IN
array-based/VBN
experiments/NNS
such/JJ
as/IN
DNA/NN
microarray/NN
,/,
arrayCGH/NN
and/CC
so/RB
on/IN
./.
====================
Currently/RB
,/,
toxicogenomic/JJ
research/NN
has/VBZ
included/VBD
'tissue/NN
microarray/NN
1/CD
experiment/NN
for/IN
efficient/JJ
confirmation/NN
for/IN
'-omics/NNS
'/``
data/NNS
./.
====================
For/IN
instance/NN
,/,
the/DT
differentially/RB
expressed/VBN
gene/NN
sets/NNS
derived/VBN
by/IN
microarray/NN
data/NNS
analysis/NN
could/MD
be/VB
easily/RB
certified/JJ
by/IN
tissue/NN
microarray/NN
./.
====================
Conventional/JJ
toxicology/NN
data/NNS
would/MD
be/VB
included/VBN
in/IN
database/NN
./.
====================
For/IN
instance/NN
histopathology/NN
image/NN
and/CC
description/NN
could/MD
be/VB
stored/VBN
in/IN
XPERANTO-TOX/NN
with/IN
own/JJ
data/NNS
model/NN
./.
====================
Finally/RB
,/,
XPERANTO-TOX/NN
could/MD
store/VB
heterogeneous/JJ
array/NN
based/VBN
high-throughput/VBP
data/NNS
,/,
and/CC
conventional/JJ
toxicology/NN
data/NNS
./.
====================
In/IN
addition/NN
,/,
this/DT
repository/JJ
would/MD
serve/VB
as/IN
a/DT
resource/NN
for/IN
discovery/NN
expression/NN
patterns/NNS
of/IN
distinct/JJ
molecules/NNS
and/CC
comparison/NN
between/IN
the/DT
patterns/NNS
./.
====================
Simple/JJ
and/CC
advanced/JJ
query/RB
forms/NNS
will/MD
be/VB
available/JJ
to/TO
retrieve/VB
information/NN
about/IN
molecular/JJ
profiling/VBG
,/,
including/VBG
nucleotide/NN
and/CC
protein/NN
sequences/NNS
as/IN
well/RB
as/IN
copy/NN
numbers/NNS
of/IN
DNA/NN
fragments/NNS
and/CC
metabolites/NNS
./.
====================
Researchers/NNS
have/VBP
applied/VBN
tens/NNS
of/IN
classical/JJ
and/CC
modified/VBN
statistical/JJ
modules/NNS
for/IN
analyzing/VBG
high-dimensional/JJ
toxicog/NN
enomics/NNS
data/NNS
./.
====================
No/DT
one/CD
knows/VBZ
about/RB
exact/VBP
population/NN
of/IN
biological/JJ
variables/NNS
./.
====================
Therefore/RB
several/JJ
algorithms/NNS
still/RB
have/VBP
been/VBN
developed/VBN
in/IN
this/DT
area/NN
./.
====================
We/PRP
determined/VBD
considerably/RB
generalized/VBN
process/NN
for/IN
analyzing/VBG
DNA/NN
microarray/NN
data/NNS
,/,
for/IN
instance/NN
./.
====================
Basically/RB
,/,
goal/NN
of/IN
DNA/NN
microarray/NN
experiment/NN
(/(
-explain/JJ
thousands/NNS
of/IN
transcripts/NNS
'/``
changes/NNS
with/IN
specific/JJ
condition/NN
)/)
is/VBZ
finding/NN
differentially/RB
expressed/VBN
gene/NN
sets/NNS
./.
====================
First/RB
step/NN
for/IN
this/DT
goal/NN
is/VBZ
data/NNS
preprocessing/VBG
through/IN
filtering/JJ
,/,
transformation/NN
,/,
imputation/NN
and/CC
normalization/NN
./.
====================
Input/RB
data/NNS
should/MD
be/VB
filtered/VBN
by/IN
determined/VBN
standard/JJ
(/(
-generally/RB
commercial/JJ
arrays/NNS
have/VBP
recommended/VBN
filtering/VBG
standard/JJ
)/)
or/CC
by/IN
flexible/JJ
decision/NN
./.
====================
Filtered/JJ
data/NNS
could/MD
be/VB
transformed/VBN
by/IN
Iog2/NN
or/CC
vsn/NN
module/NN
./.
====================
Missing/VBG
values/NNS
generated/VBN
by/IN
====================
previous/JJ
steps/NNS
are/VBP
estimated/VBN
with/IN
KNN/NN
imputation/NN
module/NN
./.
====================
For/IN
normalization/NN
,/,
cyclic/JJ
lowess/JJ
,/,
global/JJ
lowess/JJ
,/,
quantile/RB
and/CC
baseline/NN
normalization/NN
modules/NNS
are/VBP
available/JJ
./.
====================
After/IN
that/DT
,/,
scoring/VBG
statistics/NNS
would/MD
be/VB
applied/VBN
./.
====================
Because/IN
selecting/VBG
differentially/RB
expressed/VBN
genes/NNS
through/IN
distinct/JJ
conditions/NNS
is/VBZ
most/RBS
significant/JJ
parts/NNS
among/IN
the/DT
whole/JJ
process/NN
,/,
numerous/JJ
algorithms/NNS
have/VBP
been/VBN
emerged/VBN
./.
====================
We/PRP
materialized/VBD
SAM/NN
,/,
cyberT/JJ
,/,
simple/JJ
t-test/JJS
,/,
DEDS/NNS
,/,
ANOVA/NN
,/,
bayesANOVA/NN
,/,
and/CC
so/RB
on/IN
as/IN
statistical/JJ
scoring/NN
modules/NNS
./.
====================
In/IN
most/JJS
cases/NNS
,/,
selected/VBN
genes/NNS
are/VBP
still/RB
too/RB
many/JJ
to/TO
interpret/VB
individually/RB
./.
====================
For/IN
that/DT
reason/NN
,/,
clustering/NN
has/VBZ
become/VBN
essential/JJ
in/IN
this/DT
field/NN
./.
====================
Hierarchical/JJ
,/,
K-means/NNS
,/,
SOM/NN
,/,
PCA/NN
,/,
and/CC
ICA/NN
algorithms/NNS
are/VBP
available/JJ
for/IN
clustering/NN
in/IN
this/DT
system/NN
./.
====================
In/IN
addition/NN
,/,
SVM/NN
and/CC
PAM/NN
also/RB
could/MD
be/VB
implemented/VBN
for/IN
classification/NN
./.
====================
Gene/NN
has/VBZ
become/VBN
more/RBR
important/JJ
as/IN
a/DT
classifier/NN
for/IN
prognosis/NN
in/IN
medical/JJ
fields/NNS
,/,
therefore/RB
analysis/NN
system/NN
in/IN
XPERANTO-TOX/NN
would/MD
be/VB
very/RB
useful/JJ
for/IN
classification/NN
analysis/NN
with/IN
DNA/NN
microarray/NN
data/NNS
./.
====================
Actually/RB
,/,
there/EX
is/VBZ
no/DT
gold/NN
standard/JJ
for/IN
analysis/NN
./.
====================
Each/DT
algorithm/NN
has/VBZ
been/VBN
shown/VBN
different/JJ
performance/NN
in/IN
different/JJ
experiment/NN
./.
====================
So/RB
we/PRP
designed/VBD
flexible/JJ
system/NN
for/IN
extension/NN
./.
====================
If/IN
new/JJ
algorithm/NN
would/MD
be/VB
emerged/VBN
,/,
XPERANTO-/NN
TOX/NN
could/MD
easily/RB
attach/DT
new/JJ
analysis/NN
modules/NNS
./.
====================
Such/JJ
as/IN
histopathology/NN
data/NNS
from/IN
conventional/JJ
toxicology/NN
could/MD
be/VB
directly/RB
interpreted/VBN
./.
====================
Since/IN
the/DT
data/NNS
is/VBZ
just/RB
a/DT
single/JJ
image/NN
or/CC
description/NN
,/,
researchers/NNS
can/MD
recognize/VB
what/WP
it/PRP
is/VBZ
and/CC
what/WP
it/PRP
means/NNS
./.
====================
On/IN
the/DT
other/JJ
hands/NNS
,/,
toxicogenomic/JJ
data/NNS
possess/VBP
the/DT
characteristics/NNS
of/IN
high/JJ
dimension/NN
so/RB
,/,
without/IN
annotation/NN
for/IN
stored/JJ
or/CC
analyzed/VBD
data/NNS
,/,
analyst/RB
would/MD
be/VB
in/IN
trouble/JJ
with/IN
data/NNS
flood/NN
./.
====================
For/IN
example/NN
,/,
general/JJ
DNA/NN
microarray/NN
data/NNS
matrix/VBP
consists/VBZ
of/IN
myriads/NNS
row/NN
and/CC
several/JJ
tens/NNS
of/IN
columns/NNS
and/CC
the/DT
data/NNS
matrix/VBP
is/VBZ
just/RB
filled/JJ
with/IN
numbers/NNS
./.
====================
Without/IN
an/DT
assistant/JJ
,/,
toxicologist/NN
fall/JJ
into/IN
confusion/NN
with/IN
those/DT
kinds/NNS
of/IN
data/NNS
,/,
so/RB
there/EX
should/MD
be/VB
suitable/JJ
annotation/NN
system/NN
to/TO
make/VB
the/DT
data/NNS
interpretably/RB
./.
====================
There/EX
are/VBP
three/CD
data/NNS
types/NNS
in/IN
annotation/NN
system/NN
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
They/PRP
are/VBP
gene/NN
,/,
toxicant/JJ
and/CC
disease/NN
./.
====================
Those/DT
data/NNS
types/NNS
are/VBP
cross-referenced/VBN
./.
====================
Researcher/RB
can/MD
query/RB
about/RB
affected/VBN
genes/NNS
by/IN
specific/JJ
toxicant/JJ
or/CC
disease/NN
./.
====================
Query/RB
for/IN
opposite/JJ
direction/NN
also/RB
be/VB
possible/JJ
./.
====================
When/WRB
researchers/NNS
get/NN
differentially/RB
expressed/VBN
genes/NNS
by/IN
specific/JJ
toxicant/JJ
,/,
they/PRP
could/MD
be/VB
confirmed/VBN
with/IN
above/JJ
mentioned/JJ
queries/NNS
./.
====================
Data/NNS
in/IN
annotation/NN
system/NN
is/VBZ
kind/JJ
of/IN
knowledge/NN
generated/VBN
through/IN
bunch/JJ
of/IN
experiments/NNS
in/IN
wet/JJ
laboratory/NN
./.
====================
So/RB
information/NN
is/VBZ
definitely/RB
limited/JJ
./.
====================
Researchers/NNS
could/MD
get/VB
inspiration/NN
about/RB
other/JJ
effects/NNS
of/IN
certain/JJ
toxicant/JJ
and/CC
function/NN
of/IN
unknown/JJ
genes/NNS
./.
====================
Now/RB
toxicogenomics/NNS
have/VBP
the/DT
power/NN
and/CC
potentiality/NN
to/TO
revolutionize/VB
conventional/JJ
toxicology/NN
./.
====================
Several/JJ
toxicologists/NNS
begin/IN
to/TO
apply/RB
toxicogenomic/JJ
approach/NN
to/TO
understand/VB
the/DT
relationship/NN
between/IN
environmental/JJ
stress/NN
and/CC
human/JJ
disease/NN
susceptibility/NN
;/:
to/TO
identify/VB
useful/JJ
biomarkers/NNS
of/IN
disease/NN
and/CC
exposure/NN
to/TO
toxic/JJ
substances/NNS
;/:
and/CC
to/TO
elucidate/VB
the/DT
molecular/JJ
mechanisms/NNS
of/IN
toxicity/NN
./.
====================
In/IN
the/DT
vortex/NN
of/IN
this/DT
paradigm/NN
shifts/NNS
,/,
‘/CD
Toxicogenomic/JJ
knowledgebase/NN
’/CD
is/VBZ
getting/VBG
more/RBR
important/JJ
./.
====================
To/TO
store/VB
,/,
manage/VBP
,/,
analyze/VB
,/,
and/CC
annotate/JJ
toxicogenomic/JJ
data/NNS
,/,
we/PRP
recommend/VBP
the/DT
novel/JJ
system/NN
,/,
XPERANTO-TOX/NN
./.
====================
It/PRP
has/VBZ
two/CD
significant/JJ
differences/NNS
as/IN
against/IN
the/DT
existing/VBG
databases/NNS
./.
====================
First/RB
,/,
XPERANTO-/NN
TOX/NN
could/MD
store/VB
not/RB
only/RB
different/JJ
‘/NN
-omics/NNS
’/CD
data/NNS
,/,
but/CC
also/RB
conventional/JJ
toxicology/NN
data/NNS
./.
====================
Second/RB
,/,
‘/CD
Data/NNS
Analysis/NN
and/CC
Annotation/NN
System/NN
’/CD
is/VBZ
included/VBN
in/IN
XPERANTO-TOX/NN
system/NN
,/,
so/RB
analyst/NN
could/MD
easily/RB
get/NN
an/DT
insight/NN
into/IN
toxicogenomic/JJ
data/NNS
./.
====================
The/DT
whole/JJ
interface/NN
is/VBZ
not/RB
enough/IN
to/TO
serve/VB
,/,
but/CC
we/PRP
are/VBP
now/RB
performing/VBG
pilot/NN
test/NN
./.
====================
Right/NN
after/IN
that/DT
,/,
toxicologist/NN
could/MD
fully/RB
use/NN
XPERANTO-TOX/NN
./.
====================
